Trial intelligence / Profile preview

Superficial vs Deep Serratus Anterior Plane Block in Breast Cancer Surgery

jRCT1011260005Suspended

Sponsor
Asuka Pharmaceutical
Start
Jun 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of levobupivacaine in breast cancer (2 arms), sponsored by Asuka Pharmaceutical. Primary endpoint: Leakage Score at completion of sentinel lymph node biopsy. Started Jun 2026; status: suspended.

02

Drugs

levobupivacaine
03

Conditions

breast cancer

Beyond the preview

Go deeper on jRCT1011260005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1011260005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call